Evidence map›Paper›PMID 26120270›Full record

ArticleMolecular vision2015

Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.

Vlatka Brzović-Šarić, Irena Landeka, Borna Šarić, Monika Barberić, Lidija Andrijašević, Branimir Cerovski, Nada Oršolić, Domagoj Đikić

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Inflammatory Biomarkers in Diabetic Macular Edema.Journal of clinical medicine · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Vlatka Brzović-ŠarićDepartment of Ophthalmology, Sveti Duh Clinical Hospital, Sveti Duh 64, 10000 Zagreb, Croatia.
Irena LandekaLaboratory of Food Chemistry and Biochemistry, Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia.
Borna ŠarićDepartment of Ophthalmology, Sveti Duh Clinical Hospital, Sveti Duh 64, 10000 Zagreb, Croatia.
Monika BarberićMedical Diagnostics Laboratory, Sveti Duh Clinical Hospital, Zagreb, Croatia.
Lidija AndrijaševićDepartment of Ophthalmology, Sveti Duh Clinical Hospital, Sveti Duh 64, 10000 Zagreb, Croatia.
Branimir CerovskiSchool of Medicine, University of Zagreb, Croatia.
Nada OršolićDepartment of Animal Physiology, Faculty of Science, University of Zagreb, Zagreb, Croatia.
Domagoj ĐikićDepartment of Animal Physiology, Faculty of Science, University of Zagreb, Zagreb, Croatia.
University of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn diabetes, an impaired antioxidant defense system contributes to the development of diabetic retinopathy. The main objective of this paper was to find correlations of oxidative stress parameters within and between the vitreous and serum in patients with type 2 diabetes who had developed proliferative diabetic retinopathy.

methodsThe study included and compared two groups of patients who underwent vitrectomy: 37 patients with type 2 diabetes and proliferative retinopathy (PDR), and 50 patients with non-diabetic eye disorders (NDED). Vascular endothelial growth factor (VEGF), advanced oxidized protein product (AOPP), and oxidative stress markers (direct lipid hydroperoxidation (LPO), malondialdehyde (MDA), total superoxide dismutase (SOD), and glutathione (GSH)) were measured in the vitreous and serum of both groups and correlated with one another, between humoral compartments and with gender, age, and serum glucose levels.

resultsIn the vitreous of PDR patients, VEGF, LPO, and MDA (p<0.05) were increased and SOD values were slightly lowered (p<0.05) than in NDED patients. Vitreous AOPP and GSH showed no differences between the groups. In the serum, AOPP, MDA, and SOD were increased (p<0.05) and VEGF was slightly increased (p<0.05) in the PDR group compared to NDED. With regard to gender, similar changes were recorded for both groups, except for the lower serum MDA in males than females in the NDED group. Advanced age showed no significant effect on changes of measured parameters in the vitreous. In the serum, VEGF was positively correlated (p<0.05) and MDA and SOD negatively correlated (p<0.05) with increasing age. Among measured parameters within and between the vitreous and serum, several correlative links occurred in the PDR group that were not present in the NDED group. The most prominent correlation changes were between serum LPO and vitreal LPO, serum SOD and vitreal LPO, serum LPO and serum SOD, and vitreal VEGF and serum SOD.

conclusionsAmong the selected oxidative stress markers, SOD and LPO were highly correlative in both the vitreous and serum in PDR compared to patients without metabolic disorders. Their correlations suggested that monitoring their mutual alterations might be informative during PDR development and should be considered in further research.

Indexed as

Oxidative StressAdvanced Oxidation Protein ProductsAgedAged, 80 and overBiomarkersBlood GlucoseCase-Control StudiesDiabetes Mellitus, Type 2Diabetic RetinopathyFemaleGlutathioneHumansLipid PeroxidesMaleMalondialdehydeMiddle AgedAdvanced Oxidation Protein ProductsBiomarkersBlood GlucoseGlutathioneLipid PeroxidesMalondialdehydeSuperoxide DismutaseVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID26120270
PMCPMC4462954
OpenAlexW573450767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.